Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain.

GNH USA supplies Mobic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to global markets.

Mobic (meloxicam) is used to manage inflammatory and painful conditions affecting the musculoskeletal system.

- Osteoarthritis: reduces joint pain and swelling, improving mobility. - Rheumatoid arthritis: alleviates chronic inflammation and joint damage. - Juvenile rheumatoid arthritis: controls pain and inflammation in pediatric patients. - Ankylosing spondylitis: eases spinal stiffness and discomfort. - Acute pain: provides rapid relief of short‑term musculoskeletal pain.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, potentially life‑threatening. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: reduced kidney function or acute renal failure.

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risk.

- Assess cardiovascular risk: meloxicam may increase the chance of thrombotic events. - Evaluate gastrointestinal history: patients with ulcer disease need protective strategies. - Monitor renal function: NSAIDs can reduce kidney perfusion, especially in dehydrated patients. - Check hepatic status: liver enzymes may rise during therapy. - Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors: heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: increased risk of renal impairment. - Lithium: NSAIDs can raise lithium plasma levels, requiring monitoring.